Clinical trial
Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor…
NCT00301730 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00301730 |
|---|---|
| Title | Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung |
| Official title | Adoptive Immunotherapy With Costimulated Tumor-Derived T Cells After Allogeneic Hematopoietic Stem Cell Transplantation |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastatic Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | aldesleukin, therapeutic tumor infiltrating lymphocytes, trastuzumab, paclitaxel, conventional surgery |
| Enrollment | 1 |
| Start date | Oct 1, 2005 |
| First posted | Mar 13, 2006 |
| Last update posted | Apr 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: